BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38001494)

  • 1. Neutralization of extracellular histones by sodium-Β-O-methyl cellobioside sulfate in septic shock.
    Garcia B; Su F; Dewachter L; Wang Y; Li N; Remmelink M; Eycken MV; Khaldi A; Favory R; Herpain A; Moreau A; Moiroux-Sahraoui A; Manicone F; Annoni F; Shi L; Vincent JL; Creteur J; Taccone FS
    Crit Care; 2023 Nov; 27(1):458. PubMed ID: 38001494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin 1-7 in an experimental septic shock model.
    Garcia B; Su F; Manicone F; Dewachter L; Favory R; Khaldi A; Moiroux-Sahroui A; Moreau A; Herpain A; Vincent JL; Creteur J; Taccone FS; Annoni F
    Crit Care; 2023 Mar; 27(1):106. PubMed ID: 36915144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.
    He X; Su F; Taccone FS; Laporte R; Kjølbye AL; Zhang J; Xie K; Moussa MD; Reinheimer TM; Vincent JL
    Crit Care Med; 2016 Jan; 44(1):23-31. PubMed ID: 26496451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal adrenergic support in septic shock due to peritonitis.
    Sun Q; Tu Z; Lobo S; Dimopoulos G; Nagy N; Rogiers P; De Backer D; Vincent JL
    Anesthesiology; 2003 Apr; 98(4):888-96. PubMed ID: 12657850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock.
    Garcia B; Su F; Dewachter L; Favory R; Khaldi A; Moiroux-Sahraoui A; Annoni F; Vasques-Nóvoa F; Rocha-Oliveira E; Roncon-Albuquerque R; Hubesch G; Njimi H; Vincent JL; Taccone FS; Creteur J; Herpain A
    Crit Care; 2022 Sep; 26(1):281. PubMed ID: 36117167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.
    Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb S; Beale RJ; Vincent JL; Moreno R;
    Intensive Care Med; 2013 Feb; 39(2):165-228. PubMed ID: 23361625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental study.
    Rehberg S; Ertmer C; Lange M; Morelli A; Whorton E; Dünser M; Strohhäcker AK; Lipke E; Kampmeier TG; Van Aken H; Traber DL; Westphal M
    Crit Care; 2010; 14(6):R200. PubMed ID: 21054850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Euglycemic hyperinsulinemia in severe sepsis and septic shock.
    Su F; Wang Z; Bruhn A; Verdant C; Cai Y; Vincent JL
    Eur Surg Res; 2006; 38(6):495-502. PubMed ID: 17028432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentamicin improves hemodynamics in ovine septic shock after smoke inhalation injury.
    Maybauer MO; Maybauer DM; Traber LD; Westphal M; Enkhbaatar P; Morita N; Jodoin JM; Heggers JP; Herndon DN; Traber DL
    Shock; 2005 Sep; 24(3):226-31. PubMed ID: 16135961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Xuebijing injection on hemodynamics and endothelial function in patients with severe sepsis: a prospective study].
    He J; Tan Z; Zhang M; Guo L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):127-32. PubMed ID: 25665612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of ethyl pyruvate in septic shock from peritonitis.
    Su F; Wang Z; Cai Y; Remmelink M; Vincent JL
    Arch Surg; 2007 Feb; 142(2):166-71. PubMed ID: 17309968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock.
    Levy B; Nace L; Bollaert PE; Dousset B; Mallie JP; Larcan A
    Intensive Care Med; 1999 Sep; 25(9):942-8. PubMed ID: 10501749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central venous pressure value can assist in adjusting norepinephrine dosage after the initial resuscitation of septic shock.
    Li DK; Du W
    Chin Med J (Engl); 2019 May; 132(10):1159-1165. PubMed ID: 30946069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of short-term vasopressin infusion during severe septic shock.
    Patel BM; Chittock DR; Russell JA; Walley KR
    Anesthesiology; 2002 Mar; 96(3):576-82. PubMed ID: 11873030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine reduces norepinephrine requirements and preserves renal oxygenation and function in ovine septic acute kidney injury.
    Lankadeva YR; Ma S; Iguchi N; Evans RG; Hood SG; Farmer DGS; Bailey SR; Bellomo R; May CN
    Kidney Int; 2019 Nov; 96(5):1150-1161. PubMed ID: 31530477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Peroxynitrite Reduces Norepinephrine Requirements in Ovine MRSA Septic Shock.
    Fukuda S; Ihara K; Andersen CR; Randolph AC; Nelson CL; Zeng Y; Kim J; DeWitt DS; Rojas JD; Koutrouvelis A; Herndon DN; Prough DS; Enkhbaatar P
    Shock; 2019 Nov; 52(5):e92-e99. PubMed ID: 30499879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.
    Martin C; Viviand X; Arnaud S; Vialet R; Rougnon T
    Crit Care Med; 1999 Sep; 27(9):1708-13. PubMed ID: 10507587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular determinants of resuscitation from sepsis and septic shock.
    Guarracino F; Bertini P; Pinsky MR
    Crit Care; 2019 Apr; 23(1):118. PubMed ID: 30987647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury.
    Garcia B; Ter Schiphorst B; Santos K; Su F; Dewachter L; Vasques-Nóvoa F; Rocha-Oliveira E; Roncon-Albuquerque R; Uba T; Hartmann O; Picod A; Azibani F; Callebert J; Goldman S; Annoni F; Favory R; Vincent JL; Creteur J; Taccone FS; Mebazaa A; Herpain A
    Intensive Care Med Exp; 2024 Jun; 12(1):53. PubMed ID: 38849640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.